Proteolysis-targeting chimera (PROTAC) is a new technology for targeting protein degradation that has received great attention in the biomedical science community. PROTAC molecules can quickly and efficiently deplete target proteins by inducing degradation of target proteins using the ubiquitin-protease system, and can bind to substrates again to achieve multiple ubiquitination reactions, optimizing the dose dependence and drug resistance of traditional small molecules to a certain extent. However, this unique chemical structure and mechanism of action also brings many challenges to its in vivo and in vitro pharmacokinetic studies, mainly including poor solubility, poor permeability, poor oral absorption, and low bioavailability. Starting from the analysis of the physicochemical properties of PROTAC molecules, this article analyzed the pharmacokinetic characteristics and summarized the bioanalysis methods of such drugs. It also discussed the challenges and prospects of PROTAC technology, providing a reference for innovative research and breakthroughs in the field of PROTAC drugs.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |